Phase
Condition
Diabetic Neuropathy
Diabetic Macular Edema
Diabetic Vitreous Hemorrhage
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Type II diabetic patients
Using oral antidiabetic treatment for at least 3 months
Glycated hemoglobin levels > 7.5% or
Fasting glucose levels >=100mg/dl
Exclusion
Exclusion Criteria:
Type 1 diabetes patients
History of cancer under treatment
Major cardiovascular event during the last 90 days (eg. stroke, myocardial infarction)
Pregnancy
Lactation
Serious diseases presenting limited short-term prognosis (eg stage IV COPD end-stageheart failure)
Child B or C cirrhotic patients
Patients with chronic renal failure on dialysis
Study Design
Connect with a study center
Universidade do Extremo Sul Catarinense
Criciuma, Santa Catarina 88801450
BrazilSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.